Adenotonsillectomy for Obstructive Sleep-Disordered Breathing in Childhood:The Chania Community Oximetry-Based Study
Primary Purpose
Sleep Disordered Breathing, Obstructive Sleep Apnea, Adenotonsillectomy
Status
Completed
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Adenotonsillectomy (AT)
Sponsored by
About this trial
This is an interventional treatment trial for Sleep Disordered Breathing focused on measuring Apnea, Sleep Apnea Syndromes, Snoring, Sleep Apnea, Obstructive, Respiration Disorders, Respiratory Tract Diseases, Signs and Symptoms, Respiratory Signs and Symptoms, Sleep Disorders, Intrinsic, Dyssomnias, Sleep Disorders, Respiratory Sounds
Eligibility Criteria
Inclusion Criteria:
- Diagnosed with obstructive SDB (snoring >3 nights/week over the last 6 months)
- Tonsillar size >2 [Brodsky 1989]
- Considered as an AT candidate during the clinic visit by ear, nose and throat (ENT) surgeon
Exclusion Criteria:
- Recurrent tonsillitis defined as at least 3 episodes in each of the last 3 years or at least 5 episodes in each of the last 2 years or at least 7 episodes in the past year.
- Apparent craniofacial anomalies (e.g. Crouzon syndrome or Pierre-Robin sequence)
- Obstructive breathing while awake or any other clinical signs that merit prompt AT as recommended by the treating ENT physician.
- History of clinically important cardiovascular disease or cardiac arrhythmia.
- History of: sickle cell disease; symptomatic asthma; epilepsy; use of sedative medication
- History of: genetic disorders; neurological or neuromuscular disorders
- Use of: systemic or intranasal corticosteroids; montelukast
Sites / Locations
- Aghia Sophia Children's Hospital of Athens
- Chania General Hospital "St. George"
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
AT (adenotonsillectomy) Group
Control Group
Arm Description
AT (adenotonsillectomy) immediately after the baseline study evaluation
No AT (adenotonsillectomy) for 3 months after the baseline study evaluation
Outcomes
Primary Outcome Measures
Change in proportion of subjects without oxygenation abnormalities
Change in proportion of participants with a McGill oximetry score =1 (usual oxygen saturation of hemoglobin-SpO2>95%; fewer than 3 drops below 90%; and fewer than 3 clusters of desaturation events) between 3 months and 0 months.
Proportion of subjects with oxygenation abnormalities at baseline who improved at follow-up
Proportion of subjects who achieved a desaturation index (≥3% drop) of <2 episodes/h at 3 months (follow-up), if they had a desaturation index of ≥ 3.5 episodes/h at 0 months (baseline)
Secondary Outcome Measures
Somatic growth
Percent of subjects achieving an increase in weight z-score or in body mass index z-score of at least 0.5.
Abnormalities predisposing to obstructive sleep apnea (OSA) and OSA symptoms
Change in the Sleep Clinical Record score and change in Pediatric Sleep Questionnaire score, between follow-up and baseline.
Sleepiness
Change in Modified Epworth Sleepiness Scale between follow-up and baseline.
Behavioral abnormalities-1
Change in the DuPaul Questionnaire for Parents score between follow-up and baseline.
Behavioral abnormalities-2
Change in the Achenbach Questionnaire for Parents score between follow-up and baseline.
Enuresis
Percent of subjects who achieved frequency of nocturnal enuresis < 1 night per week at follow-up (3 months), if they had incontinence at least 1 night per week at baseline (0 months).
Quality of life
Change in obstructive sleep apnea syndrome (OSAS)-18 (total score) between follow-up and baseline.
Cardiovascular effects-1
Changes in mean pulse rate and mean frequency of pulse rate rises between follow-up and baseline.
Cardiovascular effects-2
Change in morning systolic and diastolic blood pressure z-score between follow-up and baseline.
Systemic inflammation
Change in morning serum C-reactive protein between follow-up and baseline.
Effects on sympathetic nervous system activation
Change in morning urine norepinephrine-corrected for urine creatinine- between follow-up and baseline.
Improvement in baseline SpO2
Proportion of subjects who had an increase from baseline in SpO2 of >1.6% according to baseline SpO2 level
Full Information
NCT ID
NCT01918007
First Posted
July 26, 2013
Last Updated
August 31, 2016
Sponsor
Chania General Hospital "St. George"
Collaborators
Aghia Sophia Children's Hospital of Athens
1. Study Identification
Unique Protocol Identification Number
NCT01918007
Brief Title
Adenotonsillectomy for Obstructive Sleep-Disordered Breathing in Childhood:The Chania Community Oximetry-Based Study
Official Title
Adenotonsillectomy for Obstructive Sleep-Disordered Breathing in Childhood:The Chania Community Oximetry-Based Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
June 2013 (undefined)
Primary Completion Date
April 2016 (Actual)
Study Completion Date
August 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Chania General Hospital "St. George"
Collaborators
Aghia Sophia Children's Hospital of Athens
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Obstructive sleep-disordered breathing (SDB) in childhood is a disorder of breathing during sleep characterized by intermittent upper airway obstruction. Snoring, labored breathing and apneas reported by the parents are the most frequent symptoms.Obstructive SDB can result from many different abnormalities including large adenoids and tonsils or obesity.
Intermittent upper airway obstruction during sleep is accompanied by low oxygen or high carbon dioxide in the blood and arousals from sleep. If obstructive SDB is not treated, complications may develop such as: i) enuresis; ii) delay in somatic growth rate; iii) central nervous system morbidity (e.g. hyperactivity and learning difficulties); and iv) elevated blood pressure.
Overnight polysomnography (PSG) is considered the gold-standard method for defining severity of obstructive SDB and subgroups of children with snoring who should be treated. However, PSG is a labor-intensive, time-consuming and expensive diagnostic method, which is not available in many community settings. Thus, there is an urgent need for developing easy-to-use and low-cost diagnostic methods which can be used to determine severity of obstructive SDB and define subgroups of children with snoring and large adenoids and tonsils who will benefit from adenotonsillectomy (AT).
Pulse oximetry is a widely available, non-invasive method which allows continuous monitoring of oxygen transport by hemoglobin. Episodes of upper airway obstruction are frequently accompanied by reductions in the hemoglobin oxygen transport (oxygen desaturation of hemoglobin).The hypothesis of this research project is that subgroups of children with snoring and adenotonsillar hypertrophy and certain abnormalities in oxygenation detected by nocturnal pulse oximetry will benefit from AT in a community setting.
Detailed Description
Time in the waiting list for undergoing AT at the Department of Otorhinolaryngology, Chania General Hospital "St. George" is approximately 3 months. In the present study, children will be recruited and randomized in the Active Comparator (AT group) or in the Control Group (No AT group) at the time of the initial clinic visit, if they fulfill the Inclusion Criteria and their parents consent to participation in the study.
Children in the AT group will undergo the baseline study evaluation at the end of the 3-month waiting time and thus immediately prior to AT. They will also undergo the follow-up study evaluation at 3 months postoperatively.
Children in the Control group will undergo their baseline study evaluation at the time of entering the surgical waiting list. They will undergo the follow-up study evaluation 3 months later, immediately prior to AT.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Disordered Breathing, Obstructive Sleep Apnea, Adenotonsillectomy, Snoring, Obstructive Sleep Disordered Breathing
Keywords
Apnea, Sleep Apnea Syndromes, Snoring, Sleep Apnea, Obstructive, Respiration Disorders, Respiratory Tract Diseases, Signs and Symptoms, Respiratory Signs and Symptoms, Sleep Disorders, Intrinsic, Dyssomnias, Sleep Disorders, Respiratory Sounds
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
186 (Actual)
8. Arms, Groups, and Interventions
Arm Title
AT (adenotonsillectomy) Group
Arm Type
Active Comparator
Arm Description
AT (adenotonsillectomy) immediately after the baseline study evaluation
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
No AT (adenotonsillectomy) for 3 months after the baseline study evaluation
Intervention Type
Procedure
Intervention Name(s)
Adenotonsillectomy (AT)
Other Intervention Name(s)
Removal of adenoids and tonsils
Intervention Description
Standard surgical intervention for treatment of Obstructive SDB.
Primary Outcome Measure Information:
Title
Change in proportion of subjects without oxygenation abnormalities
Description
Change in proportion of participants with a McGill oximetry score =1 (usual oxygen saturation of hemoglobin-SpO2>95%; fewer than 3 drops below 90%; and fewer than 3 clusters of desaturation events) between 3 months and 0 months.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Proportion of subjects with oxygenation abnormalities at baseline who improved at follow-up
Description
Proportion of subjects who achieved a desaturation index (≥3% drop) of <2 episodes/h at 3 months (follow-up), if they had a desaturation index of ≥ 3.5 episodes/h at 0 months (baseline)
Time Frame
3 months (follow-up)
Secondary Outcome Measure Information:
Title
Somatic growth
Description
Percent of subjects achieving an increase in weight z-score or in body mass index z-score of at least 0.5.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Abnormalities predisposing to obstructive sleep apnea (OSA) and OSA symptoms
Description
Change in the Sleep Clinical Record score and change in Pediatric Sleep Questionnaire score, between follow-up and baseline.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Sleepiness
Description
Change in Modified Epworth Sleepiness Scale between follow-up and baseline.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Behavioral abnormalities-1
Description
Change in the DuPaul Questionnaire for Parents score between follow-up and baseline.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Behavioral abnormalities-2
Description
Change in the Achenbach Questionnaire for Parents score between follow-up and baseline.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Enuresis
Description
Percent of subjects who achieved frequency of nocturnal enuresis < 1 night per week at follow-up (3 months), if they had incontinence at least 1 night per week at baseline (0 months).
Time Frame
3 months (follow-up)
Title
Quality of life
Description
Change in obstructive sleep apnea syndrome (OSAS)-18 (total score) between follow-up and baseline.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Cardiovascular effects-1
Description
Changes in mean pulse rate and mean frequency of pulse rate rises between follow-up and baseline.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Cardiovascular effects-2
Description
Change in morning systolic and diastolic blood pressure z-score between follow-up and baseline.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Systemic inflammation
Description
Change in morning serum C-reactive protein between follow-up and baseline.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Effects on sympathetic nervous system activation
Description
Change in morning urine norepinephrine-corrected for urine creatinine- between follow-up and baseline.
Time Frame
0 months (baseline), 3 months (follow-up)
Title
Improvement in baseline SpO2
Description
Proportion of subjects who had an increase from baseline in SpO2 of >1.6% according to baseline SpO2 level
Time Frame
0 months (baseline), 3 months (follow-up)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosed with obstructive SDB (snoring >3 nights/week over the last 6 months)
Tonsillar size >2 [Brodsky 1989]
Considered as an AT candidate during the clinic visit by ear, nose and throat (ENT) surgeon
Exclusion Criteria:
Recurrent tonsillitis defined as at least 3 episodes in each of the last 3 years or at least 5 episodes in each of the last 2 years or at least 7 episodes in the past year.
Apparent craniofacial anomalies (e.g. Crouzon syndrome or Pierre-Robin sequence)
Obstructive breathing while awake or any other clinical signs that merit prompt AT as recommended by the treating ENT physician.
History of clinically important cardiovascular disease or cardiac arrhythmia.
History of: sickle cell disease; symptomatic asthma; epilepsy; use of sedative medication
History of: genetic disorders; neurological or neuromuscular disorders
Use of: systemic or intranasal corticosteroids; montelukast
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chariton E. Papadakis, MD
Organizational Affiliation
Chania General Hospital "St. George"
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Athanasios G. Kaditis, MD
Organizational Affiliation
Aghia Sophia Children's Hospital of Athens
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Theognosia S. Chimona, MD
Organizational Affiliation
Chania General Hospital "St. George"
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Panagiota N. Asimakopoulou, MD
Organizational Affiliation
Chania General Hospital "St. George"
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Efklidis Proimos, MD
Organizational Affiliation
Chania General Hospital "St. George"
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Konstantinos Chaidas, MD
Organizational Affiliation
Aghia Sophia Children's Hospital of Athens
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Alexandra Klimentopoulou, MD
Organizational Affiliation
Aghia Sophia Children's Hospital of Athens
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aghia Sophia Children's Hospital of Athens
City
Athens
ZIP/Postal Code
11527
Country
Greece
Facility Name
Chania General Hospital "St. George"
City
Chania
ZIP/Postal Code
73300
Country
Greece
12. IPD Sharing Statement
Citations:
PubMed Identifier
14702490
Citation
Nixon GM, Kermack AS, Davis GM, Manoukian JJ, Brown KA, Brouillette RT. Planning adenotonsillectomy in children with obstructive sleep apnea: the role of overnight oximetry. Pediatrics. 2004 Jan;113(1 Pt 1):e19-25. doi: 10.1542/peds.113.1.e19.
Results Reference
background
PubMed Identifier
16997385
Citation
Saito H, Araki K, Ozawa H, Mizutari K, Inagaki K, Habu N, Yamashita T, Fujii R, Miyazaki S, Ogawa K. Pulse-oximetery is useful in determining the indications for adeno-tonsillectomy in pediatric sleep-disordered breathing. Int J Pediatr Otorhinolaryngol. 2007 Jan;71(1):1-6. doi: 10.1016/j.ijporl.2006.08.009. Epub 2006 Sep 25.
Results Reference
background
PubMed Identifier
18684748
Citation
Bonuck KA, Freeman K, Henderson J. Growth and growth biomarker changes after adenotonsillectomy: systematic review and meta-analysis. Arch Dis Child. 2009 Feb;94(2):83-91. doi: 10.1136/adc.2008.141192. Epub 2008 Aug 6.
Results Reference
background
PubMed Identifier
19336367
Citation
Wijga AH, Scholtens S, Wieringa MH, Kerkhof M, Gerritsen J, Brunekreef B, Smit HA. Adenotonsillectomy and the development of overweight. Pediatrics. 2009 Apr;123(4):1095-101. doi: 10.1542/peds.2008-1502.
Results Reference
background
PubMed Identifier
23018902
Citation
Villa MP, Paolino MC, Castaldo R, Vanacore N, Rizzoli A, Miano S, Del Pozzo M, Montesano M. Sleep clinical record: an aid to rapid and accurate diagnosis of paediatric sleep disordered breathing. Eur Respir J. 2013 Jun;41(6):1355-61. doi: 10.1183/09031936.00215411. Epub 2012 Sep 27.
Results Reference
background
PubMed Identifier
10733617
Citation
Chervin RD, Hedger K, Dillon JE, Pituch KJ. Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med. 2000 Feb 1;1(1):21-32. doi: 10.1016/s1389-9457(99)00009-x.
Results Reference
background
PubMed Identifier
15342852
Citation
Melendres MC, Lutz JM, Rubin ED, Marcus CL. Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics. 2004 Sep;114(3):768-75. doi: 10.1542/peds.2004-0730.
Results Reference
background
PubMed Identifier
16904463
Citation
Alexopoulos EI, Kostadima E, Pagonari I, Zintzaras E, Gourgoulianis K, Kaditis AG. Association between primary nocturnal enuresis and habitual snoring in children. Urology. 2006 Aug;68(2):406-9. doi: 10.1016/j.urology.2006.02.021.
Results Reference
background
PubMed Identifier
10889473
Citation
Franco RA Jr, Rosenfeld RM, Rao M. First place--resident clinical science award 1999. Quality of life for children with obstructive sleep apnea. Otolaryngol Head Neck Surg. 2000 Jul;123(1 Pt 1):9-16. doi: 10.1067/mhn.2000.105254.
Results Reference
background
PubMed Identifier
18383115
Citation
Constantin E, McGregor CD, Cote V, Brouillette RT. Pulse rate and pulse rate variability decrease after adenotonsillectomy for obstructive sleep apnea. Pediatr Pulmonol. 2008 May;43(5):498-504. doi: 10.1002/ppul.20811.
Results Reference
background
PubMed Identifier
2685730
Citation
Brodsky L. Modern assessment of tonsils and adenoids. Pediatr Clin North Am. 1989 Dec;36(6):1551-69. doi: 10.1016/s0031-3955(16)36806-7.
Results Reference
background
PubMed Identifier
31270970
Citation
Papadakis CE, Chaidas K, Chimona TS, Zisoglou M, Ladias A, Proimos EK, Miligkos M, Kaditis AG. Assessing the need for adenotonsillectomy for sleep-disordered breathing in a community setting: A secondary outcome measures analysis of a randomized controlled study. Pediatr Pulmonol. 2019 Oct;54(10):1527-1533. doi: 10.1002/ppul.24427. Epub 2019 Jul 3.
Results Reference
derived
PubMed Identifier
30087199
Citation
Papadakis CE, Chaidas K, Chimona TS, Asimakopoulou P, Ladias A, Proimos EK, Miligkos M, Kaditis AG. Use of Oximetry to Determine Need for Adenotonsillectomy for Sleep-Disordered Breathing. Pediatrics. 2018 Sep;142(3):e20173382. doi: 10.1542/peds.2017-3382. Epub 2018 Aug 7.
Results Reference
derived
Learn more about this trial
Adenotonsillectomy for Obstructive Sleep-Disordered Breathing in Childhood:The Chania Community Oximetry-Based Study
We'll reach out to this number within 24 hrs